» Articles » PMID: 26046362

Micro-RNAs Let7e and 126 in Plasma As Markers of Metabolic Dysfunction in 10 to 12 Years Old Children

Overview
Journal PLoS One
Date 2015 Jun 6
PMID 26046362
Citations 18
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Growing evidence shows that metabolic syndrome (MetS) is already starting in childhood however there is no consensus regarding how to diagnose this condition in pediatric population. Studies in adults show that altered levels of specific micro-RNAs are related with components of the MetS.

Objective: We determined the plasma levels of four MetS-associated micro-RNAs (miR-126, miR-132, mir-145 and Let-7e) in 10 to 12 years old children with or without MetS traits.

Design: Pediatric subjects were selected from a cohort of 3325 school-age children, and clustered by the absence (control, n = 30), or the presence of 1 (n = 50), 2 (n = 41) or 3 (n = 35) MetS traits according to Cook´s criteria. Micro-RNAs were isolated from plasma, and levels of miR-126, miR-132, miR-145 and Let-7e were determined by Taqman qPCR.

Results: Regression analysis of the different MetS traits regarding the different miRNAs analyzed showed that Let-7e presented a negative association with HDL-C levels, but a positive correlation with the number of MetS traits. Levels of miR-126 presented a positive correlation with waist circumference, waist to hip ratio, BMI, and plasma triglycerides and VLDL-C. Levels of miR-132 showed a positive correlation with waist to hip ratio. Plasma levels of Let-7e were increased (~3.4 fold) in subjects with 3 MetS traits, and showed significant AUC (0.681; 95%CI = [0.58, 0.78]; p < 0.001) in the ROC analysis which were improved when miR-126 was included in the analysis (AUC 0.729; p < 0.001). In silico analysis of the interaction of proteins derived from mRNAs targeted by Let7 and miR-126 showed an important effect of both Let-7e and miR-126 regulating the insulin signaling pathway.

Conclusions: These results suggest that changes in the plasma levels of Let-7e and miR-126 could represent early markers of metabolic dysfunction in children with MetS traits.

Citing Articles

Platelet-enriched microRNAs as novel biomarkers in atherosclerotic and cardiovascular disease patients.

Masoudikabir P, Shirazy M, Taghizadeh F, Gheydari M, Hamidpour M ARYA Atheroscler. 2024; 20(4):47-67.

PMID: 39717424 PMC: 11663285. DOI: 10.48305/arya.2024.41664.2898.


Plasma Extracellular MicroRNAs Associated With Cardiovascular Disease Risk Factors in Middle-Aged and Older Adults.

Karlin H, Sooda M, Larson M, Rong J, Huan T, Mens M J Am Heart Assoc. 2024; 13(12):e033674.

PMID: 38860398 PMC: 11255734. DOI: 10.1161/JAHA.123.033674.


Mechanisms and risk factors of metabolic syndrome in children and adolescents.

Codazzi V, Frontino G, Galimberti L, Giustina A, Petrelli A Endocrine. 2023; 84(1):16-28.

PMID: 38133765 PMC: 10987369. DOI: 10.1007/s12020-023-03642-x.


Circulating microRNAs Showed Specific Responses according to Metabolic Syndrome Components and Sex of Adults from a Population-Based Study.

Brandao-Lima P, de Carvalho G, Payolla T, Sarti F, Fisberg R, Malcomson F Metabolites. 2023; 13(1).

PMID: 36676927 PMC: 9861536. DOI: 10.3390/metabo13010002.


Circulating microRNA Related to Cardiometabolic Risk Factors for Metabolic Syndrome: A Systematic Review.

Brandao-Lima P, de Carvalho G, Payolla T, Sarti F, Rogero M Metabolites. 2022; 12(11).

PMID: 36355127 PMC: 9692352. DOI: 10.3390/metabo12111044.


References
1.
Chu C, Rana T . Small RNAs: regulators and guardians of the genome. J Cell Physiol. 2007; 213(2):412-9. DOI: 10.1002/jcp.21230. View

2.
. The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics. 2004; 114(2 Suppl 4th Report):555-76. View

3.
Weiss R, Bremer A, Lustig R . What is metabolic syndrome, and why are children getting it?. Ann N Y Acad Sci. 2013; 1281:123-40. PMC: 3715098. DOI: 10.1111/nyas.12030. View

4.
Liao X, Xue H, Wang Y, Nazor K, Guo S, Trivedi N . Matched miRNA and mRNA signatures from an hESC-based in vitro model of pancreatic differentiation reveal novel regulatory interactions. J Cell Sci. 2013; 126(Pt 17):3848-61. PMC: 3757328. DOI: 10.1242/jcs.123570. View

5.
Chen P, Qin L, Barnes C, Charisse K, Yi T, Zhang X . FGF regulates TGF-β signaling and endothelial-to-mesenchymal transition via control of let-7 miRNA expression. Cell Rep. 2012; 2(6):1684-96. PMC: 3534912. DOI: 10.1016/j.celrep.2012.10.021. View